Stevanato Group S.p.A STVN
NYSE STVN
$15.80 +1.49 (+10.41%)
At close: Nov 13, 2026 · 4:00 PM EST

Stevanato Group S.p.A (STVN) Return on Sales [ROS] (2020 - 2026)

Updated

Stevanato Group S.p.A's Return on Sales [ROS] came in at 18.51% for the quarter ended Sep 30, 2026, up 1.12 percentage points from 17.39% a year earlier and up 5.58 percentage points from the prior quarter.

Analysis

Stevanato Group S.p.A (STVN) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Stevanato Group S.p.A reported Return on Sales [ROS] of 16.68%, down 0.03 percentage points year-over-year; for the year ended Dec 31, 2025, it was 16.76%, up 2.16 percentage points from the prior year.

  • Return on Sales [ROS] carries a five-year change of +1.18 percentage points (years ended Dec 2020 to Dec 2025).
  • Going back by year, Return on Sales [ROS] was 14.60% in the year ended Dec 31, 2024 (-3.90 pp), 18.49% in the year ended Dec 31, 2023 (-1.07 pp), 19.56% in the year ended Dec 31, 2022 (+0.34 pp) and 19.22% in the year ended Dec 31, 2021 (+3.65 pp).
  • The five-year range for quarterly Return on Sales [ROS] is 10.72% (the quarter ended Mar 31, 2024) to 21.60% (the quarter ended Dec 31, 2022).
  • Year-over-year, Return on Sales [ROS] increased in seven of the last eight quarters, with an average year-over-year change of +1.20 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in the quarter ended Sep 30, 2022 (a gain of 6.23 percentage points), and the weakest in the quarter ended Jun 30, 2024 (a drop of 6.80 percentage points).
  • Business Quant data shows STVN's Return on Sales [ROS] at 12.93% (quarter ended Jun 30, 2026), 14.16% (quarter ended Mar 31, 2026) and 20.23% (quarter ended Dec 31, 2025) in the three quarters before the quarter ended Sep 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 18.65%
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 10.44%
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 19.00%
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 19.44%
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 18.08%
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn 15.86%
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 16.12%
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 17.44%
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 6.36%
10 Stevanato Group S.p.A 4.78 Bn 4.32 Bn 109.24 Mn 18.51%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 18.51%
Jun 30, 2026 12.93%
Mar 31, 2026 14.16%
Dec 31, 2025 20.23%
Sep 30, 2025 17.39%
Jun 30, 2025 14.77%
Mar 31, 2025 13.50%
Dec 31, 2024 20.21%
Sep 30, 2024 14.76%
Jun 30, 2024 10.77%
Mar 31, 2024 10.72%
Dec 31, 2023 19.96%
Sep 30, 2023 18.85%
Jun 30, 2023 17.57%
Mar 31, 2023 17.08%
Dec 31, 2022 21.60%
Sep 30, 2022 19.39%
Jun 30, 2022 18.71%
Mar 31, 2022 17.88%
Dec 31, 2021 18.70%
API Access

Stevanato Group S.p.A Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=STVN&period=max&api_key=YOUR_API_KEY